Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Carboplatin followed by radiation for Stage III/IV Endometrial Carcinoma
NCT00285415Phase 2Terminated
- Sponsor
- Carilion Clinic
- Start
- Apr 2005
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of docetaxel in endometrial adenocarcinoma, sponsored by Carilion Clinic. Primary endpoint: Overall Response Rate. Started Apr 2005; status: terminated.
02
Drugs
docetaxel
03
Conditions
endometrial adenocarcinoma
Beyond the preview
Go deeper on NCT00285415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00285415.